Gamma-glutamyl transferase is strongly associated with degree of overweight and sex

Journal of Pediatric Gastroenterology and Nutrition

Volumn 52, Issue 5, 2011, Pages 635-638

  Wiegand, Susanna ^a   Thamm, Michael ^b   Kiess, Wieland ^c   Körner, Antje ^c   Reinehr, Thomas ^d   Krude, Heiko ^a   Hoffmeister, Ulrike ^e   Holl, Reinhard W ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF WITTEN HERDECKE   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

Childhood obesity; gamma glutamyl transferase; metabolic syndrome; nonalcoholic fatty liver disease; pediatric cohort; sex

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ARTICLE; BODY MASS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX; SEX DIFFERENCE; SEX RATIO;

ADOLESCENT; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHILD; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; OBESITY, MORBID; ODDS RATIO; RISK FACTORS; SEX FACTORS;

EID: 79955556308     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3181f8417f     Document Type: Article

References (26)

1. Brown T, Avenell A, Edmunds LD, et al. Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults. Obes Rev 2009;10:627-38.
2. Almeda-Valdés P, Cuevas-Ramos D, Aguilar-Salinas CA. Metabolic syndrome and non-alcoholic fatty liver disease. Ann Hepatol 2009; 8:S18-24.
3. Patel DA, Srinivasan SR, Xu JH, et al. Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism 2007;56:792-8. (Pubitemid 46745298)
4. Botton J, Heude B, Andre P, et al. Relationship between gammaglutamyltransferase and fat mass in a general population of 8-17 year old children. The FLVS II study. Diab Metab 2007;33:354-9. (Pubitemid 350030904)
5. Huang RC, Mori TA, Burke V, et al. Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diab Care 2009;32:695-701.
6. Graham RC, Burke A, Stettler N. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents. J Pediatr Gastroenterol Nutr 2009;49:442-9.
7. Kurth BM, Kamtsiuris P, Hölling H, et al. The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS-Study. BMC Public Health 2008;8:196.
8. Guidelines of the German Working Group of Childhood Obesity. www.a-g-a.de. Accessed April 10, 2010.
9. Reinehr T,Wabitsch M, AndlerW, et al. Medical care of obese children and adolescents. APV: a standardised multicentre documentation derived to study initial presentation and cardiovascular risk factors in patients transferred to specialised treatment institutions. Eur J Pediatr 2004;163:308-12. (Pubitemid 38725536)
10. Kromeyer-Hauschild K, Wabitsch M, Kunze D, et al. Perzentile fü r den body-mass-index für das kindes- und jugendalter unter heranziehung verschiedener deutscher stichproben. Monatsschr Kinderheilk 2001; 149:807-18. (Pubitemid 32830649)
11. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-3. (Pubitemid 30240471)
12. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990;44:45-60. (Pubitemid 20177198)
13. Dmitrienko EA. Analysis of Clinical Trials Using SAS. Cary, NC: SAS Press; 2005.
14. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74. (Pubitemid 38702847)
15. Baranowski T, Cooper DM, Harrell J, et al. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diab Care 2006;29:212-7.
16. Wiegand S, Maikowski U, Blankenstein O, et al. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity-a problem that is no longer restricted to minority groups. Eur J Endocrinol 2004;151:199-206. (Pubitemid 39207015)
17. I'Allemand D, Wiegand S, Reinehr T, et al. Cardiovascular risk in 26,008 European overweight children as established by a multicenter database. Obesity (Silver Spring) 2008;16:1672-9. (Pubitemid 351915128)
18. Patton HM, Lavine JE, Van Natta ML, et al. Nonalcoholic steatohepatitis clinical research network. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 2008;135: 1961-71.
19. Denzer C, Thiere D, Muche R, et al. Gender-specific prevalences of fatty liver in obese children and adolescents: roles of body fat distribution, sex steroids, and insulin resistance. J Clin Endocrinol Metab 2009; 94:3872-81.
20. Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7. (Pubitemid 41475806)
21. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-33. (Pubitemid 46360389)
22. André P, Balkau B,Vol S, et al. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. Diab Care 2007;30:2355-61. (Pubitemid 47364644)
23. Gautier A, Balkau B, Lange C, et al., for the DESIR Study Group. Risk factors for incident type 2 diabetes in individuals with a BMI of
24. Dixon JB, Bhathal PS, O'Brien PE.Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006;16:1278-86. (Pubitemid 44671797)
25. Reinehr T, Schmidt C, Toschke AM, et al. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child 2009;94:437-42.
26. Kim HC, Nam CM, Jee SH, et al. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ 2004;328:983.